Advertisement
Advertisement
Business /

Money

Hong Kong’s stablecoin initiative is part of efforts to become a global digital-asset hub. Photo: Getty Images
Banking & finance

Hong Kong’s anticipated stablecoin licence by end-March does not materialise

Analysts say the delay is most likely administrative and that the overall plan is still on track.

videocam
IPO

Hong Kong retains IPO crown but may lose to US mega listings over full year

Banking & finance

Hong Kong tycoon-backed start-up raises US$300 million to scale battery push

Banking & finance

Chinese company to use AI-powered testing to boost profits and fast-track IVF

China’s falling fertility rate sees spike in demand for assisted reproduction as biotech firm raises US$101 million from Hong Kong listing.

videocam
A Chinese biotech company is hoping AI technology will help to boost profits and speed up chromosome testing which is a vital part of In vitro fertilisation. Photo: Dreamstime/TNS
A Chinese biotech company is hoping AI technology will help to boost profits and speed up chromosome testing which is a vital part of In vitro fertilisation. Photo: Dreamstime/TNS
Banking & finance

Insilico Medicine signs AI drug development deal with Eli Lilly

Reaching development, regulatory and commercial milestones could see value of deal hit around US$2.75 billion.

Mainland China

Sketching a recovery: China puts next-gen art buyers in the frame amid slowdown

A US$83 trillion global wealth transfer in next two to three decades is beginning to reshape China’s art market: UBS.

Advertisement
Advertisement
Advertisement
Biomedicine: Companies

China biotech deals hit record as innovative drugs draw global interest

Deals reach US$60 billion in first quarter after analysts say Chinese biotech firms have shown substantial technological advancements.

The US$60 billion deal value represents a 73 per cent jump from the same period a year earlier. Photo: Shutterstock
The US$60 billion deal value represents a 73 per cent jump from the same period a year earlier. Photo: Shutterstock
China property

Rising second-hand home sales offer signs China’s property slump is bottoming out

Increased resale activity, driven by first-time buyers and policy support, is fuelling hopes that China’s property market may be stabilising.

Turkey

As tensions rise, Middle Eastern money and travellers pivot to Hong Kong

Wealthy Gulf visitors are extending their stays in Hong Kong as investors from the region look to hedge risk and tap Asian markets.

Mainland China

HKIC chief sees opportunities in advanced tech across China and Hong Kong

Hong Kong government-backed investor says strong returns and co-investment flows are reinforcing the region’s appeal to global capital.

CEO of Hong Kong Investment Corp (HKIC) Clara Chan Ka-chai. Photo: Enoch Yiu
Banking & finance

Tong Ren Tang unit pulls Hong Kong IPO in first postponement this year

Hospital-network operator delays plan to raise up to US$115 million amid tepid demand.

videocam
A view of Exchange Square in Central, where Hong Kong’s bourse operator has its headquarters, on March 13, 2026. Photo: Jelly Tse
A view of Exchange Square in Central, where Hong Kong’s bourse operator has its headquarters, on March 13, 2026. Photo: Jelly Tse
Electric & new energy vehicles

China’s Pony AI to launch robotaxi service in Europe with Uber, local start-up

Partners aim to operate thousands of robotaxis in various European cities over the next few years after starting in Zagreb, Croatia, ‘soon’.

China’s private sector

China’s Jiangsu Aidea eyes Hong Kong IPO as gateway to US, European Aids markets

Yangzhou-based drug maker views Hong Kong as a ‘good window’ for its international expansion in HIV and Aids treatments.

China’s private sector

China’s obesity drug makers take on global giants as Novo Nordisk patent expires

Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss market.

Semaglutide generated about US$35 billion in global revenue last year. Photo: AFP
Wealth management

Hong Kong a ‘safe harbour’ for family wealth as global tensions rise: officials

City provides a stable platform for growth and deployment of capital amid ‘uncertainty and conflicts’, Financial Secretary Paul Chan says.

Financial Secretary Paul Chan speaks at the Wealth for Good in Hong Kong Summit gala dinner on Tuesday evening. Photo: Handout
Financial Secretary Paul Chan speaks at the Wealth for Good in Hong Kong Summit gala dinner on Tuesday evening. Photo: Handout
China’s private sector

Rights to antibody drug from China’s Keymed change hands in US acquisition

Sichuan-based Keymed expects to receive up to US$320 million as a result of deal involving its autoimmune disease treatment licensed in 2024.

Mandatory Provident Fund (MPF)

Hong Kong’s eMPF members to see 21.6% reduction in fees

The fee cut, which lowers administration costs from 0.37 per cent to 0.29 per cent, has been approved by Financial Secretary Paul Chan.

Advertisement
Advertisement
Advertisement
Banking & finance

Asian private equity values cash flow as fundraising falls to 12-year low

Advanced manufacturing and healthcare attract more attention at the expense of technology, media and telecommunications, Bain & Co says.

An employee works on a robot production line at Inovance Group in Jiangning District of Nanjing, in east China’s Jiangsu province, on March 17, 2026. Photo: Xinhua
An employee works on a robot production line at Inovance Group in Jiangning District of Nanjing, in east China’s Jiangsu province, on March 17, 2026. Photo: Xinhua
Wealth management

Hong Kong family office summit draws Pop Mart billionaire among global guests

City is ‘strong and unwavering’ as wealth management hub, Chief Executive John Lee says to kick off fourth Wealth for Good summit.

Made in China 2025

Global drug giants double down on China amid push for self-reliant supply chains

Multinationals are building self-reliant supply chains in China to insulate local markets from potential trade disruptions, say analysts.

Mainland China

Exclusive | Singapore-headquartered GLP eyes 50% rent surge as China demand fuels growth

Firm will ride Beijing’s push for domestic demand by expanding logistics, data centres and renewable energy capacity, GLP China CEO says.

A solar farm built by GLP on a fishery site in Suzhou, eastern Jiangsu province. Photo: Handout
Banking & finance

Iran conflict drives fund managers to slash risk and hoard cash: BofA survey

Fund managers pile into cash at fastest pace since Covid-19 as geopolitical tensions, inflation replace AI as top concerns, bank finds.

Investor sentiment fell to a six-month low in March, according to a BofA report. Photo: AFP
Investor sentiment fell to a six-month low in March, according to a BofA report. Photo: AFP
Banking & finance

HSBC launches US$2.5 billion AT1 bond issue in Hong Kong after market standstill

Lender’s AT1 bond sale is the first since Iran conflict froze the market, with Hong Kong’s stability making it the natural venue: analyst.

Banking & finance

Chinese banks outpace rivals in Hong Kong wealth growth, Huatai HK CEO says

Booming listings and rising outbound investment demand are accelerating growth for Chinese players, SFC data shows.

China’s private sector

US reshoring drive casts shadow over China’s contract drug makers, analyst says

Strong order backlogs underpin earnings through 2027, but analysts warn longer-term demand is less certain as US firms reshore production.

Despite the headwinds, there is growing interest from multinational pharmaceutical companies in partnering with Chinese biotech firms. Photo: Getty Images
Help preserve 120 years of quality journalism.
SUPPORT NOW